Literature DB >> 1633379

A survey of pain in hospitalized patients aged 4-14 years.

C C Johnston1, F V Abbott, K Gray-Donald, M E Jeans.   

Abstract

One hundred fifty randomly selected hospitalized children between the ages of 4-14 were interviewed to assess their pain experience in the hospital. Follow-up information was obtained through parent interviews 3 weeks, 3 months, and 6 months later. On enrollment, more than 87% of children reported having had pain within 24 h and, of those, 19% reported their usual pain intensity as in the severe range. Thirty-eight percent of children had received analgesic medication during the preceding 24 h. Children who had undergone surgery were three to four times more likely to have received narcotic analgesic than nonsurgical patients, although similar proportions in both groups reported moderate to severe pain intensity. In spite of these reports of significant pain by a substantial number of children during hospitalization, at the 3-week follow-up check, by parent report, 68% were pain free. The parents of those with pain were contacted at 3 and 6 months postenrollment, and 96% of children were no longer experiencing pain. Five children reported pain at all contact points; three of these were suffering chronic diseases and the other two had suffered major trauma from motor-vehicle accidents.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1633379     DOI: 10.1097/00002508-199206000-00015

Source DB:  PubMed          Journal:  Clin J Pain        ISSN: 0749-8047            Impact factor:   3.442


  15 in total

Review 1.  Risks and benefits of nonsteroidal anti-inflammatory drugs in children: a comparison with paracetamol.

Authors:  C Litalien; E Jacqz-Aigrain
Journal:  Paediatr Drugs       Date:  2001       Impact factor: 3.022

Review 2.  Review of systematic reviews on acute procedural pain in children in the hospital setting.

Authors:  Jennifer Stinson; Janet Yamada; Alison Dickson; Jasmine Lamba; Bonnie Stevens
Journal:  Pain Res Manag       Date:  2008 Jan-Feb       Impact factor: 3.037

Review 3.  Ketorolac for postoperative pain management in children.

Authors:  J B Forrest; E L Heitlinger; S Revell
Journal:  Drug Saf       Date:  1997-05       Impact factor: 5.606

4.  Improvements in pain outcomes in a Canadian pediatric teaching hospital following implementation of a multifaceted knowledge translation initiative.

Authors:  Lisa M Zhu; Jennifer Stinson; Lori Palozzi; Kevin Weingarten; Mary-Ellen Hogan; Silvia Duong; Ricardo Carbajal; Fiona A Campbell; Anna Taddio
Journal:  Pain Res Manag       Date:  2012 May-Jun       Impact factor: 3.037

5.  Canadian babies in pain.

Authors:  C C Johnston
Journal:  CMAJ       Date:  1994-02-15       Impact factor: 8.262

6.  Analgesic prescribing practices can be improved by low-cost point-of-care decision support.

Authors:  Glenn Rosenbluth; Stephen D Wilson; Judith H Maselli; Andrew D Auerbach
Journal:  J Pain Symptom Manage       Date:  2011-03-31       Impact factor: 3.612

7.  Postoperative pain management in children, parental English proficiency, and access to interpretation.

Authors:  Nathalia Jimenez; Douglass L Jackson; Chuan Zhou; Nelly C Ayala; Beth E Ebel
Journal:  Hosp Pediatr       Date:  2014-01

8.  Analgesic Drug Prescription Patterns on Five International Paediatric Wards.

Authors:  Sebastian Botzenhardt; Asia N Rashed; Ian C K Wong; Stephen Tomlin; Antje Neubert
Journal:  Paediatr Drugs       Date:  2016-12       Impact factor: 3.022

9.  Hospitalized children continue to report undertreated and preventable pain.

Authors:  Kathryn A Birnie; Christine T Chambers; Conrad V Fernandez; Paula A Forgeron; Margot A Latimer; Patrick J McGrath; Elizabeth A Cummings; G Allen Finley
Journal:  Pain Res Manag       Date:  2014-05-07       Impact factor: 3.037

10.  Pain prevalence in a pediatric hospital: raising awareness during Pain Awareness Week.

Authors:  Denise Harrison; Cynthia Joly; Christine Chretien; Sarah Cochrane; Jacqueline Ellis; Christine Lamontagne; Regis Vaillancourt
Journal:  Pain Res Manag       Date:  2014-01-13       Impact factor: 3.037

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.